摘要
近年肝纤维化的血清学诊断已开始应用于临床。我们用放免法测定了正常人及急慢性肝病病人血清PCⅢ含量共120例(急性肝炎25例,慢迁肝17例,慢活肝20例,肝硬化26例,肝癌8例,正常对照24例),结果:肝硬化病人血清PCⅢ含量明显增高,为正常对照组的3倍(263.7±39.84μg/L与91.44±16.52μg/L),慢活肝及肝癌亦明显增高。含量分布图显示此三组病例与正常对照组及慢迁肝组均无重叠,以肝硬化组更为明显。而且血清PCⅢ与转氨酶、白蛋白、及胆红素等指标不相关。结果表明血清PCⅢ测定可作为诊断肝纤维化的一个重要指标。
The diagnostic serology of hepatic fibrosis has been applied.In this study,the levels of serum PC Ⅲ(Precollagen TypeⅢ) were measured using radioimunoassay in 96 patients with acute or chronic liver diseases(25 acute hepatitis,20 CAH,17 CPH,26 HCH,anb 8 HCC) and 24 healthy persons.The levels of PCⅢ were abnormally increased in the patients with HCH (263.70±37.84μg/L),and three times as high as those of normal control group(91.44±16.52μg/L).The levels of PCⅢ in patients with CAH and HCC were also increased.Content distributive figure shows that these three groups didn't overlap with control or CPH, and the increase of serum PCⅢ levels wasn't correlative with serum ALT levels,albumin,and bilirubin. The results indicated that the determination of the serum PCⅢ levels may be useful in diagnosis of hepatic fibrosis.
出处
《大连医科大学学报》
CAS
1995年第1期30-32,共3页
Journal of Dalian Medical University